Makoto Iimori

5PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Microelectromechanical systems (MEMS)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 02, 2024
The anti-tumor effect of trifluridine via induction of aberrant mitosis is unaffected by mutations modulating p53 activity.

Takeshi Wakasa, Kentaro Nonaka, Akihito Harada

|May 30, 2020
DNA Replication Stress Induced by Trifluridine Determines Tumor Cell Fate According to p53 Status.

Yuki Kataoka, Makoto Iimori, Ryo Fujisawa

|May 30, 2019
Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level.

Yuki Kataoka, Makoto Iimori, Shinichiro Niimi

Pageof 1